Sean McCutcheon

Stock Analyst at Raymond James

(2.47)
# 2,242
Out of 5,152 analysts
12
Total ratings
33.33%
Success rate
9.47%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sean McCutcheon

BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $9.97
Upside: +140.72%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72$76
Current: $99.64
Upside: -23.73%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.10
Upside: +31.87%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $13.97
Upside: +365.28%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $5.53
Upside: +62.75%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.05
Upside: +436.59%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $8.71
Upside: +164.06%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58$40
Current: $11.16
Upside: +258.42%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92$70
Current: $62.19
Upside: +12.56%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $17.75
Upside: +384.51%